![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 27, 2017 10:54:08 PM
When you use the Actipatch yourself and know that it works, it becomes very very difficult to let go, as you appreciate its benefit to the nth degree. That is why the one week trial version is a brilliant approach. However, marketing to the greater public requires more than just brilliant approaches. It requires advertising, outreach, and product availability in stores. It requires distributors and partners with deep pocket. Hopefully, Biel is working dilligently and agressively to make the mega deal. With the opoids epidemic and FDA OTC clearance of the Actipatch, it can't get any better for Biel.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM